10-Q Filing

SWK Holdings Corp CIK: 1089907 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001552781-23-000439`
Period End Date	20230930
Filing Date	20231108
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	e23436_swkh-10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 76 Cash Flow Statement 70 Stockholders Equity 41

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$8.36M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$8.39M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.85M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.33M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.16M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$42.86M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.40M	USD	Point-in-time
Interest and accounts receivable, net	`AccountsReceivableNet`	$4.41M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Interest and accounts receivable, net	`AccountsReceivableNet`	$3.09M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.11M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.76M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$37.20M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $11,327 and $11,846, as of September 30, 2023 and December 31, 2022, respectively	`NotesAndLoansReceivableNetCurrent`	$223.60M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $11,327 and $11,846, as of September 30, 2023 and December 31, 2022, respectively	`NotesAndLoansReceivableNetCurrent`	$236.56M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.84M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.51M	shares	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.51M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.84M	shares	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$76.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$50.00K	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$26.09M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$24.48M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.91M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.19M	USD	Point-in-time
Goodwill	`Goodwill`	$8.40M	USD	Point-in-time
Goodwill	`Goodwill`	$8.40M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.48M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.84M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$1.74M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.06M	USD	Point-in-time
Total assets	`Assets`	$299.62M	USD	Point-in-time
Total assets	`Assets`	$315.85M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.77M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.90M	USD	Point-in-time
Revolving credit facility	`LinesOfCreditCurrent`	$22.00M	USD	Point-in-time
Revolving credit facility	`LinesOfCreditCurrent`	$2.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$24.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.35M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiability`	$11.20M	USD	Point-in-time
Contingent consideration payable	`BusinessCombinationContingentConsiderationLiability`	$11.20M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.15M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.31M	USD	Point-in-time
Total liabilities	`Liabilities`	$19.69M	USD	Point-in-time
Total liabilities	`Liabilities`	$38.28M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,510,776 and 12,843,157 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,510,776 and 12,843,157 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.15B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.15B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$273.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$274.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$277.56M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$270.80M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$271.53M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$277.45M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$267.24M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$299.62M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$315.85M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$8.50M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$25.75M	USD	3 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$8.61M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$27.15M	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$1.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$481.00K	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$39.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$108.00K	USD	3 Qtrs
Total revenues	`Revenues`	$8.96M	USD	1 Quarter
Total revenues	`Revenues`	$13.61M	USD	1 Quarter
Total revenues	`Revenues`	$31.69M	USD	3 Qtrs
Total revenues	`Revenues`	$27.87M	USD	3 Qtrs
Provision for (benefit from) credit losses	`ProvisionForOtherCreditLosses`	$-459.00K	USD	3 Qtrs
Provision for (benefit from) credit losses	`ProvisionForOtherCreditLosses`	-	USD	3 Qtrs
Provision for (benefit from) credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for (benefit from) credit losses	`ProvisionForOtherCreditLosses`	$223.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$721.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$242.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$82.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$176.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$2.83M	USD	3 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.79M	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$606.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$5.17M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$634.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$1.94M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$652.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$1.96M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$2.98M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$8.52M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$4.35M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$10.53M	USD	3 Qtrs
Income from operations	`CostsAndExpenses`	$-4.33M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-6.76M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-14.32M	USD	3 Qtrs
Income from operations	`CostsAndExpenses`	$-13.78M	USD	3 Qtrs
Unrealized net (loss) gain on warrants	`UnrealizedGainLossOnDerivatives`	$-162.00K	USD	1 Quarter
Unrealized net (loss) gain on warrants	`UnrealizedGainLossOnDerivatives`	$623.00K	USD	3 Qtrs
Unrealized net (loss) gain on warrants	`UnrealizedGainLossOnDerivatives`	$-745.00K	USD	3 Qtrs
Unrealized net (loss) gain on warrants	`UnrealizedGainLossOnDerivatives`	$1.79M	USD	1 Quarter
Unrealized net gain (loss) on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-534.00K	USD	3 Qtrs
Unrealized net gain (loss) on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Unrealized net gain (loss) on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	3 Qtrs
Unrealized net gain (loss) on equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$13.00K	USD	1 Quarter
(Loss) gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$-76.00K	USD	1 Quarter
(Loss) gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	-	USD	1 Quarter
(Loss) gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	$426.00K	USD	3 Qtrs
(Loss) gain on foreign currency transactions	`ForeignCurrencyTransactionGainBeforeTax`	-	USD	3 Qtrs
Income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.56M	USD	1 Quarter
Income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$14.00M	USD	3 Qtrs
Income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.09M	USD	1 Quarter
Income before income tax (benefit) expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$13.87M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-386.00K	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$3.21M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$959.00K	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$1.94M	USD	1 Quarter
Net income	`ProfitLoss`	$6.62M	USD	1 Quarter
Net income	`ProfitLoss`	$10.66M	USD	3 Qtrs
Net income	`ProfitLoss`	$4.47M	USD	1 Quarter
Net income	`ProfitLoss`	$13.04M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.36	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.52	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.83	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$1.03	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.36	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.02	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.83	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.51	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.70M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.83M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.83M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.54M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.87M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.58M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.85M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.75M	shares	3 Qtrs

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$6.62M	USD	1 Quarter
Net income	`ProfitLoss`	$10.66M	USD	3 Qtrs
Net income	`ProfitLoss`	$4.47M	USD	1 Quarter
Net income	`ProfitLoss`	$13.04M	USD	3 Qtrs
Benefit from credit losses	`ProvisionForOtherCreditLosses`	$-459.00K	USD	3 Qtrs
Benefit from credit losses	`ProvisionForOtherCreditLosses`	-	USD	3 Qtrs
Benefit from credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Benefit from credit losses	`ProvisionForOtherCreditLosses`	$223.00K	USD	1 Quarter
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$244.00K	USD	3 Qtrs
Right-of-use asset amortization	`FinanceLeaseRightOfUseAssetAmortization`	$171.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$26.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$243.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$915.00K	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$3.19M	USD	3 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-623.00K	USD	3 Qtrs
Change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$745.00K	USD	3 Qtrs
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$-534.00K	USD	3 Qtrs
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	3 Qtrs
Change in fair value of equity securities	`MarketableSecuritiesUnrealizedGainLoss`	$13.00K	USD	1 Quarter
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	-	USD	3 Qtrs
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	$-375.00K	USD	3 Qtrs
Loan discount and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.36M	USD	3 Qtrs
Loan discount and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$2.96M	USD	3 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$1.83M	USD	3 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$3.33M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$170.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$85.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$369.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$59.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$310.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$166.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.96M	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.94M	USD	3 Qtrs
Interest and accounts receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	$5.58M	USD	3 Qtrs
Interest and accounts receivable	`IncreaseDecreaseInInterestAndDividendsReceivable`	$1.32M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$738.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$76.00K	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-635.00K	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-603.00K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.28M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.19M	USD	3 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfEquityMethodInvestments`	$13.94M	USD	3 Qtrs
Proceeds from sale of investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	3 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$71.75M	USD	3 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$17.52M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$194.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$299.00K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-27.98M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.57M	USD	3 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	$1.34M	USD	3 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	-	USD	3 Qtrs
Proceeds from (payments on) credit facilities	`ProceedsFromRepaymentsOfLinesOfCredit`	$-8.00K	USD	3 Qtrs
Proceeds from (payments on) credit facilities	`ProceedsFromRepaymentsOfLinesOfCredit`	$19.55M	USD	3 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$6.09M	USD	3 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$599.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-767.00K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$12.12M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$24.88M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-23.46M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$31.03M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$6.16M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$42.86M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$19.40M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$31.03M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$6.16M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$42.86M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$19.40M	USD	Point-in-time

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$277.56M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$270.80M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$271.53M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$277.45M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$267.24M	USD	Point-in-time
Stock-based compensation	`ShareBasedCompensation`	$170.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$85.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$369.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$59.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$310.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$166.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$531.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$4.60M	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$599.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$963.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$6.62M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.48M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.93M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.47M	USD	1 Quarter
Net income	`NetIncomeLoss`	$565.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.63M	USD	1 Quarter
Forfeiture of unvested restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	-	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$277.56M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$270.80M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$271.53M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$277.45M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$267.24M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.